Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Madrigal Pharmaceuticals (MDGL) Q4 2023 Earnings
MDGL
28
Feb
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-5.68
-5.2
-4.71
-4.23
Details
Expected EPS
-5.238808
Actual EPS
-5.68
Surprise EPS
-0.44
Surprise Percent
+8.42%
Description
Madrigal Pharmaceuticals (MDGL) has reported earnings of -5.68 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login